| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIXT | common | Purchase | $198K | +1.59M | +7.93% | $0.12 | 21.7M | Aug 15, 2024 | by NDPD Pharma | F1 |
| transaction | BIXT | common | Other | -$3.51M | -21.7M | -100% | $0.16 | 0 | Aug 19, 2024 | by NDPD Pharma | F1, F2 |
| transaction | BIXT | preferred | Other | $3.49M | +4.34M | $0.81 | 4.34M | Aug 19, 2024 | by NDPD Pharma | F1, F2 | |
| transaction | BIXT | preferred | Conversion of derivative security | $162K | +8.97M | +206.99% | $0.02 | 13.3M | Aug 19, 2024 | by NDPD Pharma | F1 |
| transaction | BIXT | preferred | Other | $354K | +777K | +5.84% | $0.46 | 14.1M | Aug 19, 2024 | by NDPD Pharma | F1, F3 |
| transaction | BIXT | common | Other | -$411 | -411K | -100% | $0.00 | 0 | Aug 19, 2024 | by Naomi Platt | F4 |
| transaction | BIXT | preferred | Other | $411 | +82.3K | $0.01 | 82.3K | Aug 19, 2024 | by Naomi Platt | F4 | |
| transaction | BIXT | common | Other | -$43K | -43M | -100% | $0.00 | 0 | Aug 19, 2024 | Direct | F2 |
| transaction | BIXT | preferred | Other | $43K | +8.61M | $0.01 | 8.61M | Aug 19, 2024 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Total holdings by NDPD Pharma, Inc., an affiliate where the beneficial ownership includes the Companys officers, have been consolidated as indirect ownership in Davis Platt's filing. |
| F2 | A 5:1 exchange by insiders shares of Common Stock (earlier issued under Section 16b-3) into shares of Convertible Preferred Stock with a conversion ratio of 1:5 shares into Common Stock. |
| F3 | The shares were acquired through conversion of debt, issued under Rule 3(a)(9). |
| F4 | Total holdings by Naomi Platt, spouse of David Platt. |